Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma
暂无分享，去创建一个
J. Briones | E. González-Barca | J. Brouwer-Visser | K. Lechner | M. Demario | M. Hutchings | N. Ghosh | M. Dickinson | M. Kornacker | E. Nüesch | D. Rüttinger | A. Herrera | R. Cordoba | S. Rutherford | E. Labriola-Tompkins | E. Bournazou | I. Franjkovic | E. Chesne | B. Brennan | E. Nüesch | M. DeMario | R. Córdoba